Influence of partially exposed nonabsorbable membrane for alveolar ridge preservation: A randomized controlled trial.

Matumoto, Edson Ken; Corrêa, Mônica Grazieli; Couso-Queiruga, Emilio; Monteiro, Mabelle Freitas; Graham, Zachary; Braz, Silvia Helena Garcia; Ribeiro, Fernanda Vieira; Pimentel, Suzana Peres; Cirano, Fabiano Ribeiro; Casati, Marcio Zaffalon (2023). Influence of partially exposed nonabsorbable membrane for alveolar ridge preservation: A randomized controlled trial. Clinical implant dentistry and related research, 25(3), pp. 447-457. Wiley 10.1111/cid.13202

Text Clin_Implant_Dent_Rel_Res_-_2023_-_Matumoto_-_Influence_of_partially_exposed_nonabsorbable_membrane_for_alveolar_ridge.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (1MB) | Request a copy

AIM

This randomized controlled trial evaluated the impact of a partially exposed non-absorbable membrane (dPTFE) in Alveolar Ridge Preservation (ARP) procedures on clinical, tomographic, immunoenzymatic, implant-related, and patient-centered outcomes.

MATERIALS AND METHODS

Patients with a hopeless maxillary single-rooted tooth demanding rehabilitation with implants were included. Patients were randomized into two groups: dPTFE (n = 22)-tooth extraction followed by ARP using a partially exposed dPTFE membrane; USH (n = 22)-unassisted socket healing. Clinical and tomographic analyses were performed at baseline and after 3 months. After 3 months, patients received one dental implant. Implant stability quotient was obtained following implant placement. Bone-related markers were analyzed in bone biopsies using an immunoenzymatic assay.

RESULTS

Greater gain in Keratinized Mucosa Width (KMW) was observed in the dPTFE (1.33 ± 0.98 mm) compared to USH (0.59 ± 0.98 mm) (Mann-Whitney test, Z = 2,28, p < 0.05). USH showed a reduction of pain/discomfort, edema, and interference with daily life from the seventh day (Friedman/Wilcoxon test, maxT = 7.48, 8.00, and 5.92, respectively, p < 0.05). dPTFE presents a reduction of edema and interference with daily life from the 7th day and pain/discomfort from the 14th day (Friedman/Wilcoxon test, maxT = 5.40, 5.26, and 4.78, respectively, p < 0.05). The dPTFE group presented higher pain/discomfort in the 35 and 42 days and higher edema from 7 to 42 days postoperatively than USH group (Mann-Whitney test, p < 0.05). No differences between groups were observed in the tomographic measures, immunoenzymatic analysis, and implant stability (p > 0.05).

CONCLUSION

dPTFE was superior to USH by increasing KMW gain. However, dPTFE without bone graft presented similar bone loss compared to USH. This clinical trial was not registered prior to participant recruitment and randomization (NCT04329351).

Interest & Impact

Downloads

1 since deposited on 23 Mar 2023
1 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item